HDAC-IN-46

CAT: 0804-HY-150597Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-150597Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
HDAC-IN-46 (compound 12c) is a potent HDAC inhibitor with an IC50 value of 0.21 μM and 0.021 μM for HDAC1 and HDAC6, respectively. HDAC-IN-46 upregulates p-p38, and downregulates Bcl-xL and cyclin D1 in MDA-MB-231 cells. HDAC-IN-46 induces significant G2 phase arrest and apoptosis. HDAC-IN-46 can be used for researching triple-negative breast cancer (TNBC) [1].
CAS Number
[2562386-85-8]
UNSPSC
12352005
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-46.html
Solubility
10 mM in DMSO
Smiles
O=C(NO)CCCCCCCN1N=NC(C2=CC=C(C3=C(CC)N=C(N)N=C3N)C=C2)=C1
Molecular Formula
C22H30N8O2
Molecular Weight
438.53
References & Citations
[1]Wu B, et al. Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity. Bioorg Med Chem. 2020 Mar 15;28 (6) :115345.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC6

Related Products

CatalogName
HY-159109-01HDAC6-IN-46
HY-149946-01HDAC-IN-57
HY-17667HDAC-IN-95
HY-175857HDAC-IN-92
HY-174471HDAC-IN-90
HY-173330HDAC-IN-89
HY-168962HDAC-IN-88
HY-153607-01HDAC-IN-55
HY-163430HDAC-IN-71
HY-156003HDAC-IN-64

Alternative Products

CatalogName
MBS5805197HDAC-IN-46
MBS3845682-01HDAC-IN-7
M36045-01HDAC-IN-52
M35321-01HDAC-IN-40
MBS387803-01HDAC inhibitor
MBS5816721HDAC-IN-53
MBS130849-01HDAC-IN-2
MBS5806471HDAC-IN-44
MBS5821203HDAC-IN-61
MBS5815365HDAC-IN-50

Popular Products